Urology and andrology
doi: 10.25005/2074-0581-2019-21-4-638-642
FACTORS OF SPREADING THE NOSOCOMIAL URINARY TRACT INFECTION

Kh.Kh. Rizoev1, D.A. Rakhimov2, M.S. Talabzoda3

1Department of Urology, «Madadi Akbar» Clinical Hospital, Dushanbe, Republic of Tajikistan
2Republican Research and Clinical Center of Urology, Dushanbe, Republic of Tajikistan
3Department of Epidemiology and Infectious Diseases, Tajik National University, Dushanbe, Republic of Tajikistan

Objective: Exploring the factors which contributes the spreading the nosocomial urinary tract infection (NUTI).

Methods: Random sampling method analyzed 248 medical cards of patients with benign prostatic hyperplasia for 2016-2018. 154 of them were underwent open adenomectomy, and 94 – transurethral resection of the prostate (TURP). The prevalence of NUTI was studied depending on the patient’s age, duration of surgery, duration preoperative period and duration of bladder catheterization.

Results: In 31 cases, the NUTI was identified, which amounted to 12.5%. After the open adenomectomy, the NUTI had 21 observations (13.6%), and after the TURP – in 10 cases (10.6%). The most typical manifestations of NUTI were: urethritis – 32.2%, postoperative wound suppuration – 25.8%, cystitis – 19.3%. It has been found that the frequency of development of NUTI is influenced by the duration of the preoperative period. Thus, among patients who had no more than 2 days of preoperative surgery, the NUTI was 5 times less common than patients with a longer preoperative period, with a frequency of 5.0% and 26.1%, respectively (р<0.001). Statistically significant differences in the frequency of NUTI was found, depending on the duration of catheterization of the bladder: at the terms of catheterization up to 6 days and more than 6 days frequency of NUTI was 6.5% and 22.6% respectively (р<0.001).

Conclusion: The most frequent clinical manifestations of NUTI were the suppuration of postoperative wound and urethritis. The main factors influencing the spread of NUTI are the duration of the preoperative period and the duration of bladder catheterization.

Keywords: Benign prostatic hyperplasia, open adenomectomy, transurethral resection of the prostate, urinary infection tract, nosocomial infection.

Download file:

References
  1. Vertkin AL, Loran OB, Vovk EI, Zimin ON, Naumov AV, Pak AD, i dr. Dobrokachestvennaya giperplaziya predstatel’noy zhelezy i eyo oslozhneniya v obshemeditsinskoy praktike [Benign prostatic hyperplasia and its complications in general medical practice]. Zdorov’e muzhchiny. 2011;4:16-9.
  2. Alyaev YuG, Glybochko PV, Pushkar DYu. (red.) Urologiya. Rossiyskie klinicheskie rekomendatsii [Urology. Russian clinical guidelines]. Moscow, RF: GEOTAR-Media; 2016. 496 p.
  3. Rasstroystva mocheispuskaniya vsledstvie giperplazii predstatel’noy zhelezy [Disorders of urination due to prostatic hyperplasia]. Statya predostavlena i perevedena kompaniey «PAUL HARTMANN». Effektivnaya pharmakoterapiya. Urologiya. 2012;1:34-6.
  4. Sernyak PS, Forostynya SP. Evolyutsiya usovershensvovaniya diagnostiki i lecheniya dobrokachestvennoy giperplazii predstatel’noy zhelezy [Evolution of improvement of diagnostics and treatment of the prostate gland benign hyperplasia]. Arkhiv klinicheskoy i eksperimental’noy meditsiny. 2010;19(1):70-2.
  5. American Urological Association Guideline: Management of Benign Prostatic Hyperplasia. American Urological Association. 2010. 494 p.
  6. Fibbi B, Penna G, Morelli A. Chronic inflammation in the pathogenesis of benign prostatic hyperplasia. Int J Androl. 2010;33(3):475-88.
  7. Konoplya AI, Krasnov AV, Loktionov AL. Immunometabolicheskie narusheniya u bol’nykh s sochetaniem dobrokachestvennoy giperplazii predstatel’noy zhelezy i khronicheskogo prostatita v posleoperatsionnom periode [Immunometabolic disturbances in patients with a combination of a hyperplasia of a prostate and chronic prostatitis in the postoperative period]. Vestnik novykh meditsinskikh tekhnologiy. 2010;17(1):170-2.
  8. Tusmatov ShM, Nusratulloev IN, Rafiev KhK. Vnutribol’nichnaya infektsiya u posleoperatsionnykh bol’nykh s dobrokachestvennoy giperplaziey predstatel’noy zhelezy [Nosocomial infections in postoperative patients with benign prostatic hyperplasia]. Vestnik Avitsenny [Avicenna Bulletin]. 2015;4:53-6.
  9. Grabe M. (chairman), Bjerklund-Johansen TE, Botto H, et al. Guidelines on Urological Infections. European Association of Urology. 2013;(3). 106 р.
  10. Kwon YK, Choe MS, Seo KW, The effect of intraprostatic chronic inflammation on benign prostatic hyperplasia treatment. Korean J Urol. 2010;51(4):266-70.
  11. Kuznetsov VV. Faktory riska razvitiya posleoperatsionnykh infektsionno-vospalitel’nykh oslozhneniy u patsientov s dobrokachestvennoy giperplaziey predstatel’noy zhelezy i otsenka ikh informatsionnoy znachimosti [Risk factors development of infective inflammatory complications in patients with prostate benign hyperplasia and their informative assessment.]. Zhurnal Grodnenskogo gosudarstvennogo meditsinskogo universiteta. 2013;4:65-70.
  12. Lopatkin NA, Apolikhin OI, Pushkar DYu, Perepanova TS. Antimikrobnaya terapiya i profilaktika infektsii pochek, mochevyvodyashchikh putey i muzhskikh polovykh organov: Rossiyskie natsional’nye rekomendatsii [Antimicrobial therapy and prevention of infections of the kidneys, urinary tract and the male reproductive organs]. Moscow, RF: 2013. 64 p.
  13. Kramar OG, Savchenko TN. Vnutribol’nichnye infektsii [Hospital infections]. Vestnik Volgogradskogo gosudarstvennogo meditsinskogo universiteta. 2010;34(2):3-7.
  14. Berezhnova TA. Zabolevaemost’ vnutribol’nichnymi infektsiyami v lechebno-profilakticheskikh uchrezhdeniyakh i faktory riska [Incidence of care-associated infection in medical-prophylactic institutions and risk factors]. Vestnik eksperimental’noy i klinicheskoy khirurgii. 2010;3(4):440-1.
  15. Derevyanko TI, Laypanov IM, Ryzhkov VV, Kadiev RM. Profilaktika infektsionno-vospalitel’nykh oslozhneniy posle otkrytykh khirurgicheskikh i endourologicheskikh manipulyatsiy na organakh mochevyvodyashshikh putey i reproduktivnoy sistemy u muzhchin [Prevention of infectious and inflammatory complications after open surgical and endourological manipulations on the urinary tract and reproductive system in men]. Effektivnaya pharmakoterapiya. 2013;1:6-10.
  16. Glybochko PV, Anafin TG, Shalekenov SB. Kombinirovannoe endockopicheskoe lechenie bol’nykh adenomoy predstatel’noy zhelezy [Combined endoscopic treatment of patients with prostate adenoma]. Urologiya. 2011;6:81-3.
  17. Belotserkovskiy BZ, Gelfand BR, Milyukova IA, Gelfand EB. Epidemiologicheskiy monitoring nozokomial’nykh infektsiy [Epidemiological monitoring of nosocomial infections]. Infektsii v khirurgii. 2013;11(2):44-50.
  18. Pasechnikov SP, Saydakova NA, Kuznetsov VV. Rezul’taty kompleksnoy sistemnoy profilaktiki posleoperatsionnykh infektsionno-vospalitel’nykh oslozhneniy u bol’nykh dobrokachestvennoy giperplaziey predstatel’noy zhelezy [The results of complex systemic prevention of postoperative infectious and inflammatory complications in patients with benign prostatic hyperplasia]. Urologiya, andrologiya i nefrologiya. 2014;18:5-11.
  19. Tarasenko SV, Bogomolov AYu, Zaytsev OV, Peskov OD, Natalskiy AA, Sokolova SN, i dr. ERAS – sovremennaya kontseptsiya vedeniya khirurgicheskikh bol’nykh. Sobstvennyy opyt [ERAS is a modern concept for the management of surgical patients. Own experience]. Nauka molodykh. 2016;3:67-71.
  20. Kendzhaeva IA, Satorov S, Saidov KhM, Akhmedova GM, Nazarov N, Rakhmatullaeva MN, i dr. Kharakteristika vozbuditeley gnoyno-vospalitel’nykh zabolevaniy v detskom khirurgicheskom gnoyno-septicheskom otdelenii [Characteristics of pathogens of purulent-inflammatory diseases in children’s surgical septic department]. Zdravookhranenie Tadzhikistana. 2010;4:29-33.
  21. Yunusov IA, Talabov MS, Rizoev KhKh. Chastota i struktura vnutribol’nichnykh infektsiy sredi bol’nykh khirurgicheskogo profilya [Frequency and structure of nosocomial infections among surgical patients]. Vestnik Akademii meditsinskikh nauk Tadzhikistana. 2019;9(2):209-14. Available from: https://doi. org/10.31712/2221-7355-2019-9-2-209-214.

Authors' information:

Rizoev Khayriddin Khayrullaevich
Candidate of Medical Sciences, Head of the Department of Urology, «Madadi Akbar» Clinical Hospital
ORCID ID: 0000-0002-1572-9289
SPIN: 7648-0341
E-mail: hai_riz@mail.ru

Rakhimov Dilshod Abdufattoevich
Candidate of Medical Sciences, Research Fellow, Republican Urology Research and Clinical Center
ORCID ID: 0000-0003-4825-9700
SPIN: 6051-7586
E-mail: dilik0102@mail.ru

Talabzoda Muhammadali Sayf
Doctor of Medical Sciences, Professor, Department of Epidemiology and Infectious Diseases, Tajik National University
ORCID ID: 0000-0001-7755-1482
SPIN: 4571-9800
E-mail: m.talabov@mail.ru

Information about support in the form of grants, equipment, medications

The authors did not receive financial support from manufacturers of medicines and medical equipment

Conflicts of interest: No conflict

Address for correspondence:

Rizoev Khayriddin Khayrullaevich
Candidate of Medical Sciences, Head of the Department of Urology, «Madadi Akbar» Clinical Hospital

734025, Republic of Tajikistan, Dushanbe, Ayni str., 14a

Tel.: +992 (985) 419091

E-mail: hai_riz@mail.ru

Materials on the topic:
  1. VARICOCELE RELAPSE CAUSES
  2. METHAPHYLAXIS OF NEPHROLITHIASIS IN CHILDREN AT THE ENDEMIC REGION

◄ Back to the list